Cited by 65Lipid metabolism and biosynthesisProtein Kinase Regulation and GTPase SignalingSphingolipid Metabolism and Signaling

How is the acyl chain composition of phosphoinositides created and does it matter?

Open access
Barneda, David, Cosulich, Sabina, Stephens, Len, Hawkins, Phillip·2019·Biochemical Society Transactions

Abstract

The phosphoinositide (PIPn) family of signalling phospholipids are central regulators in membrane cell biology. Their varied functions are based on the phosphorylation pattern of their inositol ring, which can be recognized by selective binding domains in their effector proteins and be modified by a series of specific PIPn kinases and phosphatases, which control their interconversion in a spatial and temporal manner. Yet, a unique feature of PIPns remains largely unexplored: their unusually uniform acyl chain composition. Indeed, while most phospholipids present a range of molecular species comprising acyl chains of diverse length and saturation, PIPns in several organisms and tissues show the predominance of a single hydrophobic backbone, which in mammals is composed of arachidonoyl and stearoyl chains. Despite evolution having favoured this specific PIPn configuration, little is known regarding the mechanisms and functions behind it. In this review, we explore the metabolic pathways that could control the acyl chain composition of PIPns as well as the potential roles of this selective enrichment. While our understanding of this phenomenon has been constrained largely by the technical limitations in the methods traditionally employed in the PIPn field, we believe that the latest developments in PIPn analysis should shed light onto this old question.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/bst20190205

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mammalian PI and its derivatives predominantly have stearic acid at the sn-1 position and arachidonic acid at the sn-2 position.

    “The fatty acids linked to the glycerol backbone are predominantly, stearic acid (C18:0; 18 carbons with no double bonds) at the sn-1 position and arachidonic acid (C20:4; 20 carbons with 4 double bonds) at sn-2 position [5,6] (Figure 1B).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 127 · Cited by 65

Research works printed but not linked: 125

  1. [1]Dickson E.J. and Hille B. (2019) Understanding phosphoinositides: rare, dynamic, and essential membrane phospholipids. Biochem. J. 476, 1– 23 10.1042/BCJ20180022 30617162 PMC6342281 · DOI · Paper page
  2. [2]Hammond G.R. and Balla T. (2015) Polyphosphoinositide binding domains: key to inositol lipid biology. Biochim. Biophys. Acta 1851, 746– 758 10.1016/j.bbalip.2015.02.013 25732852 PMC4380703 · DOI
  3. [3]Harayama T. and Riezman H. (2018) Understanding the diversity of membrane lipid composition. Nat. Rev. Mol. Cell Biol. 19, 281 10.1038/nrm.2017.138 29410529 · DOI
  4. [4]Harayama T., Eto M., Shindou H., Kita Y., Otsubo E., Hishikawa D. et al. (2014) Lysophospholipid acyltransferases mediate phosphatidylcholine diversification to achieve the physical properties required in vivo. Cell Metab. 20, 295– 305 10.1016/j.cmet.2014.05.019 24981836 · DOI
  5. [5]Anderson K.E., Kielkowska A., Durrant T.N., Juvin V., Clark J., Stephens L.R. et al. (2013) Lysophosphatidylinositol-acyltransferase-1 (LPIAT1) is required to maintain physiological levels of PtdIns and PtdInsP(2) in the mouse. PLoS ONE 8, e58425 10.1371/journal.pone.0058425 23472195 PMC3589398 · DOI
  6. [6]Lee H.C., Inoue T., Sasaki J., Kubo T., Matsuda S., Nakasaki Y. et al. (2012) LPIAT1 regulates arachidonic acid content in phosphatidylinositol and is required for cortical lamination in mice. Mol. Biol. Cell 23, 4689– 4700 10.1091/mbc.e12-09-0673 23097495 PMC3521678 · DOI
  7. [7]Imae R., Inoue T., Nakasaki Y., Uchida Y., Ohba Y., Kono N. et al. (2012) LYCAT, a homologue of C. elegans acl-8, acl-9, and acl-10, determines the fatty acid composition of phosphatidylinositol in mice. J. Lipid Res. 53, 335– 347 10.1194/jlr.M018655 22172515 PMC3276457 · DOI
  8. [8]Gaudette D.C., Aukema H.M., Jolly C.A., Chapkin R.S. and Holub B.J. (1993) Mass and fatty acid composition of the 3-phosphorylated phosphatidylinositol bisphosphate isomer in stimulated human platelets. J. Biol. Chem. 268, 13773– 13776 PMID: 8390977
  9. [9]Anderson K.E., Juvin V., Clark J., Stephens L.R. and Hawkins P.T. (2016) Investigating the effect of arachidonate supplementation on the phosphoinositide content of MCF10a breast epithelial cells. Adv. Biol. Regul. 62, 18– 24 10.1016/j.jbior.2015.11.002 26639089 PMC5061326 · DOI
  10. [10]Blunsom N.J. and Cockcroft S. (2019) Phosphatidylinositol synthesis at the endoplasmic reticulum. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 10.1016/j.bbalip.2019.05.015 31173893 · DOI · Paper page
  11. [11]Tamura Y., Harada Y., Nishikawa S.-., Yamano K., Kamiya M., Shiota T. et al. (2013) Tam41 is a CDP-diacylglycerol synthase required for cardiolipin biosynthesis in mitochondria. Cell Metab. 17, 709– 718 10.1016/j.cmet.2013.03.018 23623749 PMC3654088 · DOI
  12. [12]Blunsom N.J., Gomez-Espinosa E., Ashlin T.G. and Cockcroft S. (2018) Mitochondrial CDP-diacylglycerol synthase activity is due to the peripheral protein, TAMM41 and not due to the integral membrane protein, CDP-diacylglycerol synthase 1. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1863, 284– 298 10.1016/j.bbalip.2017.12.005 29253589 PMC5791848 · DOI
  13. [13]Bahmanyar S., Biggs R., Schuh A.L., Desai A., Muller-Reichert T., Audhya A. et al. (2014) Spatial control of phospholipid flux restricts endoplasmic reticulum sheet formation to allow nuclear envelope breakdown. Genes Dev. 28, 121– 126 10.1101/gad.230599.113 24449268 PMC3909786 · DOI
  14. [14]Triebl A., Trötzmüller M., Eberl A., Hanel P., Hartler J. and Köfeler H.C. (2014) Quantitation of phosphatidic acid and lysophosphatidic acid molecular species using hydrophilic interaction liquid chromatography coupled to electrospray ionization high resolution mass spectrometry. J. Chromatogr. A 1347, 104– 110 10.1016/j.chroma.2014.04.070 24813932 PMC6013042 · DOI
  15. [15]Thompson W. and Macdonald G. (1976) Cytidine diphosphate diglyceride of bovine brain: positional distribution of fatty acids and analysis of major molecular species. Eur. J. Biochem. 65, 107– 111 10.1111/j.1432-1033.1976.tb10394.x 776622 · DOI
  16. [16]Saito S., Goto K., Tonosaki A. and Kondo H. (1997) Gene cloning and characterization of CDP-diacylglycerol synthase from rat brain. J. Biol. Chem. 272, 9503– 9509 10.1074/jbc.272.14.9503 9083091 · DOI
  17. [17]D'Souza K., Kim Y.J., Balla T. and Epand R.M. (2014) Distinct properties of the two isoforms of CDP-diacylglycerol synthase. Biochemistry 53, 7358– 7367 10.1021/bi501250m 25375833 PMC4255645 · DOI
  18. [18]Papatheodorou I., Fonseca N.A., Keays M., Tang Y.A., Barrera E., Bazant W. et al. (2017) Expression atlas: gene and protein expression across multiple studies and organisms. Nucleic Acids Res. 46, D246– D251 10.1093/nar/gkx1158 PMC5753389 29165655 · DOI
  19. [19]Blunsom N.J., Gomez-Espinosa E., Ashlin T.G. and Cockcroft S. (2019) Sustained phospholipase C stimulation of H9c2 cardiomyoblasts by vasopressin induces an increase in CDP-diacylglycerol synthase 1 (CDS1) through protein kinase C and cFos. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1864, 1072– 1082 10.1016/j.bbalip.2019.03.002 30862571 PMC6495107 · DOI
  20. [20]D'Souza K. and Epand R.M. (2015) The phosphatidylinositol synthase-catalyzed formation of phosphatidylinositol does not exhibit acyl chain specificity. Biochemistry 54, 1151– 1153 10.1021/bi5015634 25633188 · DOI
  21. [21]Holub B. and Kuksis A. (1971) Differential distribution of orthophosphate-32P and glycerol-14C among molecular species of phosphatidylinositols of rat liver in vivo. J. Lipid Res. 12, 699– 705 PMID: 4330924
  22. [22]Nakagawa Y., Rüstow B., Rabe H., Kunze D. and Waku K. (1989) The de novo synthesis of molecular species of phosphatidylinositol from endogenously labeled CDP diacylglycerol in alveolar macrophage microsomes. Arch. Biochem. Biophys. 268, 559– 566 10.1016/0003-9861(89)90323-8 2913948 · DOI
  23. [23]Luthra M. and Sheltawy A. (1976) The metabolic turnover of molecular species of phosphatidylinositol and its precursor phosphatidic acid in Guinea-pig cerebral hemispheres. J. Neurochem. 27, 1503– 1511 10.1111/j.1471-4159.1976.tb02636.x 1003224 · DOI
  24. [24]Holub B. and Piekarski J. (1976) Biosynthesis of molecular species of CDP-diglyceride from endogenously-labeled phosphatidate in rat liver microsomes. Lipids 11, 251– 257 10.1007/BF02544050 1263770 · DOI
  25. [25]Postle A.D., Heeley E.L. and Wilton D.C. (2001) A comparison of the molecular species compositions of mammalian lung surfactant phospholipids. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 129, 65– 73 10.1016/S1095-6433(01)00306-3 11369534 · DOI
  26. [26]Hishikawa D., Hashidate T., Shimizu T. and Shindou H. (2014) Diversity and function of membrane glycerophospholipids generated by the remodeling pathway in mammalian cells. J. Lipid Res. 55, 799– 807 10.1194/jlr.R046094 24646950 PMC3995458 · DOI
  27. [27]Lee H.-C., Inoue T., Imae R., Kono N., Shirae S., Matsuda S. et al. (2008) Caenorhabditis elegans mboa-7, a member of the MBOAT family, is required for selective incorporation of polyunsaturated fatty acids into phosphatidylinositol. Mol. Biol. Cell 19, 1174– 1184 10.1091/mbc.e07-09-0893 18094042 PMC2262980 · DOI
  28. [28]Gijon M.A., Riekhof W.R., Zarini S., Murphy R.C. and Voelker D.R. (2008) Lysophospholipid acyltransferases and arachidonate recycling in human neutrophils. J. Biol. Chem. 283, 30235– 30245 10.1074/jbc.M806194200 18772128 PMC2573059 · DOI
  29. [29]Imae R., Inoue T., Kimura M., Kanamori T., Tomioka N.H., Kage-Nakadai E. et al. (2010) Intracellular phospholipase A1 and acyltransferase, which are involved in Caenorhabditis elegans stem cell divisions, determine the sn-1 fatty acyl chain of phosphatidylinositol. Mol. Biol. Cell 21, 3114– 3124 10.1091/mbc.e10-03-0195 20668164 PMC2938378 · DOI
  30. [30]Cao J., Liu Y., Lockwood J., Burn P. and Shi Y. (2004) A novel cardiolipin-remodeling pathway revealed by a gene encoding an endoplasmic reticulum-associated acyl-CoA: lysocardiolipin acyltransferase (ALCAT1) in mouse. J. Biol. Chem. 279, 31727– 31734 10.1074/jbc.M402930200 15152008 · DOI
  31. [31]Agarwal A.K., Barnes R.I. and Garg A. (2006) Functional characterization of human 1-acylglycerol-3-phosphate acyltransferase isoform 8: cloning, tissue distribution, gene structure, and enzymatic activity. Arch. Biochem. Biophys. 449, 64– 76 10.1016/j.abb.2006.03.014 16620771 · DOI
  32. [32]Zhao Y., Chen Y.-Q., Li S., Konrad R.J. and Cao G. (2009) The microsomal cardiolipin remodeling enzyme acyl-CoA lysocardiolipin acyltransferase is an acyltransferase of multiple anionic lysophospholipids. J. Lipid Res. 50, 945– 956 10.1194/jlr.M800567-JLR200 19075029 PMC2666181 · DOI
  33. [33]Bone L.N., Dayam R.M., Lee M., Kono N., Fairn G.D., Arai H. et al. (2017) The acyltransferase LYCAT controls specific phosphoinositides and related membrane traffic. Mol. Biol. Cell 28, 161– 172 10.1091/mbc.e16-09-0668 28035047 PMC5221620 · DOI
  34. [34]Choy C.H., Han B.-K. and Botelho R.J. (2017) Phosphoinositide diversity, distribution, and effector function: stepping out of the box. Bioessays 39, 1700121 10.1002/bies.201700121 28977683 · DOI
  35. [36]Thabet K., Asimakopoulos A., Shojaei M., Romero-Gomez M., Mangia A., Irving W.L. et al. (2016) MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C. Nat. Commun. 7, 12757 10.1038/ncomms12757 27630043 PMC5027609 · DOI
  36. [37]Thabet K., Chan H.L.Y., Petta S., Mangia A., Berg T., Boonstra A. et al. (2017) The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B. Hepatology 65, 1840– 1850 10.1002/hep.29064 28109005 · DOI
  37. [38]Xia Y., Huang C.X., Li G.Y., Chen K.H., Han L., Tang L. et al. (2019) Meta-analysis of the association between MBOAT7 rs641738, TM6SF2 rs58542926 and nonalcoholic fatty liver disease susceptibility. Clin. Res. Hepatol. Gastroenterol. 43, 533– 541 10.1016/j.clinre.2019.01.008 30824369 · DOI
  38. [39]Mancina R.M., Dongiovanni P., Petta S., Pingitore P., Meroni M., Rametta R. et al. (2016) The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of european descent. Gastroenterology 150, 1219– 1230.e6 10.1053/j.gastro.2016.01.032 26850495 PMC4844071 · DOI · Paper page
  39. [40]Luukkonen P.K., Zhou Y., Hyötyläinen T., Leivonen M., Arola J., Orho-Melander M. et al. (2016) The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans. J. Hepatol. 65, 1263– 1265 10.1016/j.jhep.2016.07.045 27520876 · DOI
  40. [41]Kainu V., Hermansson M. and Somerharju P. (2008) Electrospray ionization mass spectrometry and exogenous heavy isotope-labeled lipid species provide detailed information on aminophospholipid acyl chain remodeling. J. Biol. Chem. 283, 3676– 3687 10.1074/jbc.M709176200 18056998 · DOI
  41. [42]Darnell J.C., Osterman D.G. and Saltiel A.R. (1991) Synthesis of phosphatidylinositol in rat liver microsomes is accompanied by the rapid formation of lysophosphatidylinositol. Biochim. Biophys. Acta Lipids Lipid Metab. 1084, 269– 278 10.1016/0005-2760(91)90069-T 1888775 · DOI
  42. [43]Schaloske R.H. and Dennis E.A. (2006) The phospholipase A2 superfamily and its group numbering system. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1761, 1246– 1259 10.1016/j.bbalip.2006.07.011 16973413 · DOI
  43. [44]Balsinde J., Ackermann E.J., Conde-Frieboes K. and Dennis E.A. (1995) Inhibition of calcium-independent phospholipase A2 prevents arachidonic acid incorporation and phospholipid remodeling in P388D1 macrophages. Proc. Natl Acad. Sci. U.S.A. 92, 8527– 8531 10.1073/pnas.92.18.8527 7667324 PMC41190 · DOI
  44. [45]Balsinde J., Balboa M.A. and Dennis E.A. (1997) Antisense inhibition of group VI Ca2+-independent phospholipase A2 blocks phospholipid fatty acid remodeling in murine P388D1 macrophages. J. Biol. Chem. 272, 29317– 29321 10.1074/jbc.272.46.29317 9361012 · DOI
  45. [46]Murakami M., Masuda S., Ueda-Semmyo K., Yoda E., Kuwata H., Takanezawa Y. et al. (2005) Group VIB Ca2+-independent phospholipase A2γ promotes cellular membrane hydrolysis and prostaglandin production in a manner distinct from other intracellular phospholipases A2. J. Biol. Chem. 280, 14028– 14041 10.1074/jbc.M413766200 15695510 · DOI
  46. [47]Cheon Y., Kim H.-W., Igarashi M., Modi H.R., Chang L., Ma K. et al. (2012) Disturbed brain phospholipid and docosahexaenoic acid metabolism in calcium-independent phospholipase A2-VIA (iPLA2β)-knockout mice. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1821, 1278– 1286 10.1016/j.bbalip.2012.02.003 PMC3393806 22349267 · DOI
  47. [48]Yamashita A., Kumazawa T., Koga H., Suzuki N., Oka S. and Sugiura T. (2010) Generation of lysophosphatidylinositol by DDHD domain containing 1 (DDHD1): possible involvement of phospholipase D/phosphatidic acid in the activation of DDHD1. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1801, 711– 720 10.1016/j.bbalip.2010.03.012 20359546 · DOI
  48. [49]Oka S., Nakajima K., Yamashita A., Kishimoto S. and Sugiura T. (2007) Identification of GPR55 as a lysophosphatidylinositol receptor. Biochem. Biophys. Res. Commun. 362, 928– 934 10.1016/j.bbrc.2007.08.078 17765871 · DOI
  49. [50]Alhouayek M., Masquelier J. and Muccioli G.G. (2018) Lysophosphatidylinositols, from cell membrane constituents to GPR55 ligands. Trends Pharmacol. Sci. 39, 586– 604 10.1016/j.tips.2018.02.011 29588059 · DOI
  50. [51]Inloes J.M., Jing H. and Cravatt B.F. (2018) The spastic paraplegia-associated phospholipase DDHD1 is a primary brain phosphatidylinositol lipase. Biochemistry 57, 5759– 5767 10.1021/acs.biochem.8b00810 30221923 PMC6237197 · DOI
  51. [52]Masquelier J. and Muccioli G.G. (2016) Development and validation of a specific and sensitive HPLC-ESI-MS method for quantification of lysophosphatidylinositols and evaluation of their levels in mice tissues. J. Pharm. Biomed. Anal. 126, 132– 140 10.1016/j.jpba.2016.04.011 27208623 · DOI
  52. [53]Mariggiò S., Sebastià J., Filippi B.M., Iurisci C., Volonté C., Amadio S. et al. (2006) A novel pathway of cell growth regulation mediated by a PLA2α-derived phosphoinositide metabolite. FASEB J. 20, 2567– 2569 10.1096/fj.05-5397fje 17060404 · DOI
  53. [54]Murase S. and Okuyama H. (1985) A membrane-bound phospholipase C with an apparent specificity for lysophosphatidylinositol in porcine platelets. J. Biol. Chem. 260, 262– 265 PMID: 3917432
  54. [55]Aoki J., Taira A., Takanezawa Y., Kishi Y., Hama K., Kishimoto T. et al. (2002) Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J. Biol. Chem. 277, 48737– 48744 10.1074/jbc.M206812200 12354767 · DOI
  55. [56]Yamashita A., Oka S., Tanikawa T., Hayashi Y., Nemoto-Sasaki Y. and Sugiura T. (2013) The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55. Prostaglandins Other Lipid Mediat. 107, 103– 116 10.1016/j.prostaglandins.2013.05.004 23714700 · DOI
  56. [57]Yamashita A., Hayashi Y., Matsumoto N., Nemoto-Sasaki Y., Koizumi T., Inagaki Y. et al. (2017) Coenzyme-A-independent transacylation system; possible involvement of phospholipase A2 in transacylation. Biology 6, 23 10.3390/biology6020023 PMC5485470 28358327 · DOI
  57. [58]Schlame M. (2013) Cardiolipin remodeling and the function of tafazzin. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1831, 582– 588 10.1016/j.bbalip.2012.11.007 23200781 · DOI
  58. [59]Kim Y.J., Guzman-Hernandez M.L. and Balla T. (2011) A highly dynamic ER-derived phosphatidylinositol-synthesizing organelle supplies phosphoinositides to cellular membranes. Dev. Cell 21, 813– 824 10.1016/j.devcel.2011.09.005 22075145 PMC3235737 · DOI
  59. [60]English A.R. and Voeltz G.K. (2013) Rab10 GTPase regulates ER dynamics and morphology. Nat. Cell Biol. 15, 169 10.1038/ncb2647 23263280 PMC3582403 · DOI
  60. [61]Tábara L.C., Vicente J.-J., Biazik J., Eskelinen E.-L., Vincent O. and Escalante R. (2018) Vacuole membrane protein 1 marks endoplasmic reticulum subdomains enriched in phospholipid synthesizing enzymes and is required for phosphoinositide distribution. Traffic 19, 624– 638 10.1111/tra.12581 29761602 · DOI
  61. [62]Nishimura T., Tamura N., Kono N., Shimanaka Y., Arai H., Yamamoto H. et al. (2017) Autophagosome formation is initiated at phosphatidylinositol synthase-enriched ER subdomains. EMBO J. 36, 1719 10.15252/embj.201695189 28495679 PMC5470044 · DOI
  62. [63]Michell R.H. (1975) Inositol phospholipids and cell surface receptor function. Biochim. Biophys. Acta Rev. Biomembr. 415, 81– 147 10.1016/0304-4157(75)90017-9 164246 · DOI
  63. [64]Thillaiappan N.B., Chakraborty P., Hasan G. and Taylor C.W. (2018) IP3 receptors and Ca2+ entry. Biochim. Biophys. Acta Mol. Cell Res. 1866, 1092– 1100 10.1016/j.bbamcr.2018.11.007 30448464 · DOI
  64. [65]Gallegos L.L. and Newton A.C. (2008) Spatiotemporal dynamics of lipid signaling: protein kinase C as a paradigm. IUBMB Life 60, 782– 789 10.1002/iub.122 18720411 PMC2718795 · DOI
  65. [66]Pettitt T.R. and Wakelam M.J. (1999) Diacylglycerol kinase ε, but not ζ, selectively removes polyunsaturated diacylglycerol, inducing altered protein kinase C distribution in vivo. J. Biol. Chem. 274, 36181– 36186 10.1074/jbc.274.51.36181 10593903 · DOI
  66. [67]Chen Y.-J., Quintanilla C.G. and Liou J. (2019) Recent insights into mammalian ER–PM junctions. Curr. Opin. Cell Biol. 57, 99– 105 10.1016/j.ceb.2018.12.011 30739879 PMC6462233 · DOI
  67. [68]Cockcroft S. and Raghu P. (2018) Phospholipid transport protein function at organelle contact sites. Curr. Opin. Cell Biol. 53, 52– 60 10.1016/j.ceb.2018.04.011 29859321 PMC6141807 · DOI
  68. [69]Saheki Y. and Camilli P.D. (2017) Endoplasmic reticulum–plasma membrane contact sites. Annu. Rev. Biochem. 86, 659– 684 10.1146/annurev-biochem-061516-044932 28301744 · DOI
  69. [70]Kim Y.J., Guzman-Hernandez M.-L., Wisniewski E. and Balla T. (2015) Phosphatidylinositol-phosphatidic acid exchange by Nir2 at ER-PM contact sites maintains phosphoinositide signaling competence. Dev. Cell 33, 549– 561 10.1016/j.devcel.2015.04.028 26028218 PMC4476625 · DOI
  70. [71]Kim S., Kedan A., Marom M., Gavert N., Keinan O., Selitrennik M. et al. (2013) The phosphatidylinositol-transfer protein Nir2 binds phosphatidic acid and positively regulates phosphoinositide signalling. EMBO Rep. 14, 891– 899 10.1038/embor.2013.113 23897088 PMC3807235 · DOI
  71. [72]Chang C.-L., Hsieh T.-S., Yang T.T., Rothberg K.G., Azizoglu D.B., Volk E. et al. (2013) Feedback regulation of receptor-induced Ca2+ signaling mediated by E-Syt1 and Nir2 at endoplasmic reticulum-plasma membrane junctions. Cell Rep. 5, 813– 825 10.1016/j.celrep.2013.09.038 24183667 · DOI
  72. [73]Saheki Y., Bian X., Schauder C.M., Sawaki Y., Surma M.A., Klose C. et al. (2016) Control of plasma membrane lipid homeostasis by the extended synaptotagmins. Nat. Cell Biol. 18, 504 10.1038/ncb3339 27065097 PMC4848133 · DOI
  73. [74]Lung M., Shulga Y.V., Ivanova P.T., Myers D.S., Milne S.B., Brown H.A. et al. (2009) Diacylglycerol kinase ɛ is selective for both acyl chains of phosphatidic acid or diacylglycerol. J. Biol. Chem. 284, 31062– 31073 10.1074/jbc.M109.050617 19744926 PMC2781506 · DOI
  74. [75]Shulga Y.V., Anderson R.A., Topham M.K. and Epand R.M. (2012) Phosphatidylinositol-4-phosphate 5-kinase isoforms exhibit acyl chain selectivity for both substrate and lipid activator. J. Biol. Chem. 287, 35953– 35963 10.1074/jbc.M112.370155 22942276 PMC3476263 · DOI
  75. [76]Epand R.M. (2017) Features of the phosphatidylinositol cycle and its role in signal transduction. J. Membr. Biol. 250, 353– 366 10.1007/s00232-016-9909-y 27278236 · DOI
  76. [77]de Turco E.B.R., Tang W., Topham M.K., Sakane F., Marcheselli V.L., Chen C. et al. (2001) Diacylglycerol kinase ɛ regulates seizure susceptibility and long-term potentiation through arachidonoyl–inositol lipid signaling. Proc. Natl Acad. Sci. U.S.A. 98, 4740– 4745 10.1073/pnas.081536298 11287665 PMC31904 · DOI
  77. [78]Takemasu S., Ito M., Morioka S., Nigorikawa K., Kofuji S., Takasuga S. et al. (2019) Lysophosphatidylinositol-acyltransferase-1 is involved in cytosolic Ca2+ oscillations in macrophages. Genes Cells 24, 366– 376 10.1111/gtc.12681 30851234 · DOI
  78. [79]Stephens L., Anderson K., Stokoe D., Erdjument-Bromage H., Painter G.F., Holmes A.B. et al. (1998) Protein kinase B kinases that mediate phosphatidylinositol 3,4,5–trisphosphate-dependent activation of protein kinase B. Science 279, 710– 714 10.1126/science.279.5351.710 9445477 · DOI
  79. [80]Rohács T., Chen J., Prestwich G.D. and Logothetis D.E. (1999) Distinct specificities of inwardly rectifying K+ channels for phosphoinositides. J. Biol. Chem. 274, 36065– 36072 10.1074/jbc.274.51.36065 10593888 · DOI
  80. [81]Wong L.H., Gatta A.T. and Levine T.P. (2019) Lipid transfer proteins: the lipid commute via shuttles, bridges and tubes. Nat. Rev. Mol. Cell Biol. 20, 85– 101 10.1038/s41580-018-0071-5 30337668 · DOI
  81. [82]Wang Y., Mousley C.J., Lete M.G. and Bankaitis V.A. (2019) An equal opportunity collaboration between lipid metabolism and proteins in the control of membrane trafficking in the trans-Golgi and endosomal systems. Curr. Opin. Cell Biol. 59, 58– 72 10.1016/j.ceb.2019.03.012 31039522 PMC7198063 · DOI
  82. [83]Antonny B., Bigay J. and Mesmin B. (2018) The oxysterol-binding protein cycle: burning off PI(4)P to transport cholesterol. Annu. Rev. Biochem. 87, 809– 837 10.1146/annurev-biochem-061516-044924 29596003 · DOI
  83. [84]Schauder C.M., Wu X., Saheki Y., Narayanaswamy P., Torta F., Wenk M.R. et al. (2014) Structure of a lipid-bound extended synaptotagmin indicates a role in lipid transfer. Nature 510, 552 10.1038/nature13269 24847877 PMC4135724 · DOI
  84. [85]Chung J., Torta F., Masai K., Lucast L., Czapla H., Tanner L.B. et al. (2015) PI4P/phosphatidylserine countertransport at ORP5-and ORP8-mediated ER–plasma membrane contacts. Science 349, 428– 432 10.1126/science.aab1370 26206935 PMC4638224 · DOI
  85. [86]Ghai R., Du X., Wang H., Dong J., Ferguson C., Brown A.J. et al. (2017) ORP5 and ORP8 bind phosphatidylinositol-4, 5–biphosphate (PtdIns (4, 5) P 2) and regulate its level at the plasma membrane. Nat. Commun. 8, 757 10.1038/s41467-017-00861-5 28970484 PMC5624964 · DOI
  86. [87]Nishimura T., Gecht M., Covino R., Hummer G., Surma M.A., Klose C. et al. (2019) Osh proteins control nanoscale lipid organization necessary for PI(4,5)P2 synthesis. Mol. Cell 75, 1043– 1057.e8 10.1016/j.molcel.2019.06.037 31402097 PMC6739424 · DOI · Paper page
  87. [88]Garner K., Hunt A.N., Koster G., Somerharju P., Groves E., Li M. et al. (2012) Phosphatidylinositol transfer protein, cytoplasmic 1 (PITPNC1) binds and transfers phosphatidic acid. J. Biol. Chem. 287, 32263– 32276 10.1074/jbc.M112.375840 22822086 PMC3442557 · DOI
  88. [89]Jacobsen R.G., Mazloumi Gavgani F., Edson A.J., Goris M., Altankhuyag A. and Lewis A.E. (2019) Polyphosphoinositides in the nucleus: roadmap of their effectors and mechanisms of interaction. Adv. Biol. Regul. 72, 7– 21 10.1016/j.jbior.2019.04.001 31003946 · DOI
  89. [90]Fiume R., Faenza I., Sheth B., Poli A., Vidalle M.C., Mazzetti C. et al. (2019) Nuclear phosphoinositides: their regulation and roles in nuclear functions. Int. J. Mol. Sci. 20, 2991 10.3390/ijms20122991 PMC6627530 31248120 · DOI
  90. [91]Sobol M., Krausová A., Yildirim S., Kalasová I., Fáberová V., Vrkoslav V. et al. (2018) Nuclear phosphatidylinositol 4, 5–bisphosphate islets contribute to efficient RNA polymerase II-dependent transcription. J Cell Sci 131, jcs211094 10.1242/jcs.211094 29507116 · DOI
  91. [92]Blind R.D., Sablin E.P., Kuchenbecker K.M., Chiu H.-J., Deacon A.M., Das D. et al. (2014) The signaling phospholipid PIP3 creates a new interaction surface on the nuclear receptor SF-1. Proc. Natl Acad. Sci. U.S.A. 111, 15054– 15059 10.1073/pnas.1416740111 25288771 PMC4210282 · DOI
  92. [93]Blind R.D., Suzawa M. and Ingraham H.A. (2012) Direct modification and activation of a nuclear receptor–PIP2 complex by the inositol lipid kinase IPMK. Sci. Signal. 5, ra44 10.1126/scisignal.2003111 22715467 PMC3395721 · DOI · Paper page
  93. [94]Choi S., Chen M., Cryns V.L. and Anderson R.A. (2019) A nuclear phosphoinositide kinase complex regulates p53. Nat. Cell Biol. 21, 462– 475 10.1038/s41556-019-0297-2 30886346 PMC7017954 · DOI · Paper page
  94. [95]Michell R.H. (2008) Inositol derivatives: evolution and functions. Nat. Rev. Mol. Cell Biol. 9, 151 10.1038/nrm2334 18216771 · DOI
  95. [96]Brown J.R. and Auger K.R. (2011) Phylogenomics of phosphoinositide lipid kinases: perspectives on the evolution of second messenger signaling and drug discovery. BMC Evol. Biol. 11, 4 10.1186/1471-2148-11-4 21208444 PMC3024228 · DOI
  96. [97]Schneiter R., Brügger B., Sandhoff R., Zellnig G., Leber A., Lampl M. et al. (1999) Electrospray ionization tandem mass spectrometry (ESI-MS/MS) analysis of the lipid molecular species composition of yeast subcellular membranes reveals acyl chain-based sorting/remodeling of distinct molecular species en route to the plasma membrane. J. Cell Biol. 146, 741– 754 10.1083/jcb.146.4.741 10459010 PMC2156145 · DOI · Paper page
  97. [98]McCourt P. and Somerville C. (1986) A mutant of Arabidopsis deficient in C18: 3 and C16: 3 leaf lipids. Plant Physiol. 81, 859– 864 10.1104/pp.81.3.859 16664915 PMC1075440 · DOI
  98. [99]Kaliszewski P., Ferreira T., Gajewska B., Szkopinska A., Berges T. and Żołądek T. (2006) Enhanced levels of Pis1p (phosphatidylinositol synthase) improve the growth of Saccharomyces cerevisiae cells deficient in Rsp5 ubiquitin ligase. Biochem. J. 395, 173– 181 10.1042/BJ20051726 16363994 PMC1409703 · DOI
  99. [100]Le Guédard M., Bessoule J.-J., Boyer V., Ayciriex S., Velours G., Kulik W. et al. (2009) PSI1 is responsible for the stearic acid enrichment that is characteristic of phosphatidylinositol in yeast. FEBS J. 276, 6412– 6424 10.1111/j.1742-4658.2009.07355.x 19796168 · DOI
  100. [101]Doignon F., Laquel P., Testet E., Tuphile K., Fouillen L. and Bessoule J.-J. (2016) Requirement of phosphoinositides containing stearic acid to control cell polarity. Mol. Cell. Biol. 36, 765– 780 10.1128/MCB.00843-15 PMC4760214 26711260 · DOI
  101. [102]Riekhof W.R., Wu J., Gijón M.A., Zarini S., Murphy R.C. and Voelker D.R. (2007) Lysophosphatidylcholine metabolism in Saccharomyces cerevisiae the role of P-type ATPases in transport and a broad specificity acyltransferase in acylation. J. Biol. Chem. 282, 36853– 36861 10.1074/jbc.M706718200 17951629 · DOI
  102. [103]Steinhauer J., Gijón M.A., Riekhof W.R., Voelker D.R., Murphy R.C., Treisman J.E. et al. (2009) Drosophila lysophospholipid acyltransferases are specifically required for germ cell development. Mol. Biol. Cell 20, 5224– 5235 10.1091/mbc.e09-05-0382 19864461 PMC2793297 · DOI
  103. [104]Yoshioka T., Inoue H., Kasama T., Seyama Y., Nakashima S., Nozawa Y. et al. (1985) Evidence that arachidonic acid is deficient in phosphatidylinositol of Drosophila heads. J. Biochem. 98, 657– 662 10.1093/oxfordjournals.jbchem.a135322 3936840 · DOI
  104. [105]Clark J., Kay R.R., Kielkowska A., Niewczas I., Fets L., Oxley D. et al. (2014) Dictyostelium uses ether-linked inositol phospholipids for intracellular signalling. EMBO J. 33, 2188– 2200 10.15252/embj.201488677 25180230 PMC4282506 · DOI
  105. [106]Schreiber F., Patricio M., Muffato M., Pignatelli M. and Bateman A. (2014) Treefam v9: a new website, more species and orthology-on-the-fly. Nucleic Acids Res. 42, D922– D925 10.1093/nar/gkt1055 24194607 PMC3965059 · DOI
  106. [107]Hicks A.M., DeLong C.J., Thomas M.J., Samuel M. and Cui Z. (2006) Unique molecular signatures of glycerophospholipid species in different rat tissues analyzed by tandem mass spectrometry. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1761, 1022– 1029 10.1016/j.bbalip.2006.05.010 16860597 · DOI
  107. [108]Mujalli A., Chicanne G., Bertrand-Michel J., Viars F., Stephens L., Hawkins P. et al. (2018) Profiling of phosphoinositide molecular species in human and mouse platelets identifies new species increasing following stimulation. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1863, 1121– 1131 10.1016/j.bbalip.2018.06.009 29902570 · DOI
  108. [109]Ren M., Xu Y., Erdjument-Bromage H., Donelian A., Phoon C.K.L., Terada N. et al. (2019) Extramitochondrial cardiolipin suggests a novel function of mitochondria in spermatogenesis. J. Cell Biol. 218, 1491– 1502 10.1083/jcb.201808131 30914420 PMC6504895 · DOI
  109. [110]Llorente A., Skotland T., Sylvänne T., Kauhanen D., Róg T., Orłowski A. et al. (2013) Molecular lipidomics of exosomes released by PC-3 prostate cancer cells. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1831, 1302– 1309 10.1016/j.bbalip.2013.04.011 24046871 · DOI
  110. [111]Brzozowski J.S., Jankowski H., Bond D.R., McCague S.B., Munro B.R., Predebon M.J. et al. (2018) Lipidomic profiling of extracellular vesicles derived from prostate and prostate cancer cell lines. Lipids Health Dis. 17, 211 10.1186/s12944-018-0854-x 30193584 PMC6128989 · DOI
  111. [112]Durcin M., Fleury A., Taillebois E., Hilairet G., Krupova Z., Henry C. et al. (2017) Characterisation of adipocyte-derived extracellular vesicle subtypes identifies distinct protein and lipid signatures for large and small extracellular vesicles. J. Extracell. Vesicles 6, 1305677 10.1080/20013078.2017.1305677 28473884 PMC5405565 · DOI
  112. [113]Rüstow B., Nakagawa Y., Rabe H., Waku K. and Kunze D. (1988) Species pattern of phosphatidylinositol from lung surfactant and a comparison of the species pattern of phosphatidylinositol and phosphatidylglycerol synthesized de novo in lung microsomal fractions. Biochem. J. 254, 67– 71 10.1042/bj2540067 3178759 PMC1135040 · DOI
  113. [114]van den Bogaart G., Meyenberg K., Risselada H.J., Amin H., Willig K.I., Hubrich B.E. et al. (2011) Membrane protein sequestering by ionic protein–lipid interactions. Nature 479, 552 10.1038/nature10545 22020284 PMC3409895 · DOI · Paper page
  114. [115]Traynor-Kaplan A., Kruse M., Dickson E.J., Dai G., Vivas O., Yu H., et al. (2017) Fatty-acyl chain profiles of cellular phosphoinositides. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1862, 513– 522 10.1016/j.bbalip.2017.02.002 28189644 PMC5392126 · DOI
  115. [117]He M., Guo S. and Li Z. (2015) In situ characterizing membrane lipid phenotype of breast cancer cells using mass spectrometry profiling. Sci. Rep. 5, 11298 10.1038/srep11298 26061164 PMC4462148 · DOI
  116. [118]Goto T., Terada N., Inoue T., Nakayama K., Okada Y., Yoshikawa T. et al. (2014) The expression profile of phosphatidylinositol in high spatial resolution imaging mass spectrometry as a potential biomarker for prostate cancer. PLoS ONE 9, e90242 10.1371/journal.pone.0090242 24587297 PMC3938652 · DOI
  117. [119]Kawashima M., Iwamoto N., Kawaguchi-Sakita N., Sugimoto M., Ueno T., Mikami Y. et al. (2013) High-resolution imaging mass spectrometry reveals detailed spatial distribution of phosphatidylinositols in human breast cancer. Cancer Sci. 104, 1372– 1379 10.1111/cas.12229 23837649 PMC7656533 · DOI
  118. [120]Naguib A., Bencze G., Engle D.D., Chio I.I.C., Herzka T., Watrud K. et al. (2015) P53 mutations change phosphatidylinositol acyl chain composition. Cell Rep. 10, 8– 19 10.1016/j.celrep.2014.12.010 25543136 PMC4287966 · DOI
  119. [121]Rueda-Rincon N., Bloch K., Derua R., Vyas R., Harms A., Hankemeier T. et al. (2015) P53 attenuates AKT signaling by modulating membrane phospholipid composition. Oncotarget 6, 21240 10.18632/oncotarget.4067 26061814 PMC4673262 · DOI
  120. [122]Bui H.H., Sanders P.E., Bodenmiller D., Kuo M.S., Donoho G.P. and Fischl A.S. (2018) Direct analysis of PI(3,4,5)P3 using liquid chromatography electrospray ionization tandem mass spectrometry. Anal. Biochem. 547, 66– 76 10.1016/j.ab.2018.02.014 29470948 · DOI
  121. [123]Kielkowska A., Niewczas I., Anderson K.E., Durrant T.N., Clark J., Stephens L.R. et al. (2014) A new approach to measuring phosphoinositides in cells by mass spectrometry. Adv. Biol. Regul. 54, 131– 141 10.1016/j.jbior.2013.09.001 24120934 · DOI
  122. [124]Bravo J., Karathanassis D., Pacold C.M., Pacold M.E., Ellson C.D., Anderson K.E. et al. (2001) The crystal structure of the PX domain from p40phox bound to phosphatidylinositol 3-phosphate. Mol. Cell 8, 829– 839 10.1016/S1097-2765(01)00372-0 11684018 · DOI
  123. [125]Tilley S.J., Skippen A., Murray-Rust J., Swigart P.M., Stewart A., Morgan C.P. et al. (2004) Structure-function analysis of phosphatidylinositol transfer protein α bound to human phosphatidylinositol. Structure 12, 317– 326 10.1016/j.str.2004.01.013 14962392 · DOI
  124. [126]Whorton M.R. and MacKinnon R. (2011) Crystal structure of the mammalian GIRK2K+ channel and gating regulation by G proteins, PIP2, and sodium. Cell 147, 199– 208 10.1016/j.cell.2011.07.046 21962516 PMC3243363 · DOI
  125. [127]von Filseck J.M., Čopič A., Delfosse V., Vanni S., Jackson C.L., Bourguet W. et al. (2015) Phosphatidylserine transport by ORP/Osh proteins is driven by phosphatidylinositol 4-phosphate. Science 349, 432– 436 10.1126/science.aab1346 26206936 · DOI

Authors
Barneda, D., Cosulich, S., Stephens, L., & Hawkins, P.
Affiliations
  • AstraZeneca (United Kingdom) (GB)
  • Babraham Institute (GB)
Corresponding author
Barneda, David
Venue
Biochemical Society Transactions
Published
2019-10-28
Volume
47
Issue
5
Pages
1291-1305
ISSN
  • 0300-5127 (ISSN-L)
  • 1470-8752
OpenAlex
W2981565897
Cited by
65
References
127
Citations by year
2026: 7 · 2025: 10 · 2024: 6 · 2023: 11 · 2022: 8 · 2021: 7 · 2020: 13 · 2019: 3
FWCI
0.85
Type
journal article
Language
en
Open access
Locations
  • Biochemical Society Transactions (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Biotechnology and Biological Sciences Research Council (BBS/E/B/000C0432, BBS/E/B/000C0415, BB/T002530/1, BB/P013384/1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
Keywords
phosphoinositides, acyl chain composition, phosphoinositide kinases, phosphoinositide phosphatase, phosphoinositide metabolism, molecular species, phosphoinositide signaling, phospholipid analysis
MeSH terms
Animals, Binding Sites, Phosphatidylinositols, Signal Transduction, 1-Phosphatidylinositol 4-Kinase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review